Home › NDC Lookup › RxCUI directory › RxCUI 727355

4 ML adenosine 3 MG/ML Prefilled Syringe — RxCUI 727355

Name: 4 ML adenosine 3 MG/ML Prefilled Syringe (RxCUI 727355)
Creator: Brian Staiger, PharmD

RxNorm drug concept · Semantic clinical drug

RxCUI 727355 Semantic clinical drug · SCD ● Current RxNorm concept 5 FDA products 8 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by Dr. Brian Staiger, PharmD

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI727355

Official name4 ML adenosine 3 MG/ML Prefilled Syringe

Concept typeSemantic clinical drug (SCD)

RxNorm statusCurrent RxNorm concept

Also known asadenosine 12 MG per 4 ML Prefilled Syringe; adenosine 12 MG in 4 ML Prefilled Syringe

FDA products mapped5

Package NDCs mapped8

Reported Medicaid activity (SDUD)11 prescriptions · 1 state & territory Medicaid programs · latest period Q4 2025

RxNorm release07/06/2026

Snapshot dataJul 14, 2026

🕸️ Concept Web — How 4 ML adenosine 3 MG/ML Prefilled Syringe Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.

This page's concept 4 ML adenosine 3 MG/ML Prefilled Syringe RxCUI 727355 Semantic clinical drug · SCD

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

Ingredients 1

The active substance itself — no strength, form, or brand attached yet.
- Adenosine 296 IN
Brand names 1

The same medicine's trade names. A brand name alone says nothing about strength or form.
- Adenocard 258345 BN
Dose forms 6

The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
- Adenosine Prefilled Syringe 727353 SCDF
- Adenosine Injectable Product 1153467 SCDG
- Adenosine Prefilled Syringe [Adenocard] 727356 SBDF
- Adenocard Injectable Product 1170624 SBDG
- Prefilled Syringe 721656 DF
- Injectable Product 1151126 DFG
Clinical & branded drugs 3

Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
- Adenosine 3 MG/ML 315283 SCDC
- 4 ML adenosine 3 MG/ML Prefilled Syringe [Adenocard] 727357 SBD
- Adenosine 3 MG/ML [Adenocard] 573584 SBDC

Showing up to 8 concepts per family — 11 of 11 stored related concepts drawn.

These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

Adenosine 3 MG/ML SCDC · 315283
Adenosine Prefilled Syringe SCDF · 727353
Adenosine Injectable Product SCDG · 1153467

Brand-Name Concepts

4 ML adenosine 3 MG/ML Prefilled Syringe [Adenocard] SBD · 727357
Adenosine 3 MG/ML [Adenocard] SBDC · 573584
Adenosine Prefilled Syringe [Adenocard] SBDF · 727356
Adenocard Injectable Product SBDG · 1170624
Adenocard BN · 258345

📦 FDA Products & Package NDCs

5 products · 8 package NDCs

8 package NDCs map to RxCUI 727355 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.

Package NDC	Package	Brand / generic name	Labeler	Marketing start
25021-0301-67	10 SYRINGE in 1 CARTON (25021-301-67) / 2 mL in 1 SYRINGE	adenosine	Sagent Pharmaceuticals	2014-04-16
25021-0301-68	10 SYRINGE in 1 CARTON (25021-301-68) / 4 mL in 1 SYRINGE	adenosine	Sagent Pharmaceuticals	2014-04-16
51662-1511-01	1 SYRINGE in 1 CARTON (51662-1511-1) / 4 mL in 1 SYRINGE	ADENOSINE	HF Acquisition Co LLC, DBA HealthFirst	2021-01-21
51662-1643-03	10 POUCH in 1 CASE (51662-1643-3) / 1 SYRINGE in 1 POUCH (5...	ADENOSINE	HF Acquisition Co LLC, DBA HealthFirst	2018-04-16
63323-0651-89	10 SYRINGE, PLASTIC in 1 CARTON (63323-651-89) / 2 mL in 1...	Adenosine	Fresenius Kabi USA, LLC	2018-04-16
63323-0651-90	10 SYRINGE, PLASTIC in 1 CARTON (63323-651-90) / 4 mL in 1...	Adenosine	Fresenius Kabi USA, LLC	2018-04-16
68083-0101-01	10 SYRINGE in 1 CARTON (68083-101-01) / 2 mL in 1 SYRINGE	Adenosine	Gland Pharma Limited	2013-04-01
68083-0101-02	10 SYRINGE in 1 CARTON (68083-101-02) / 4 mL in 1 SYRINGE	Adenosine	Gland Pharma Limited	2013-04-01

Observed labelers: Fresenius Kabi USA, LLC (2) · Gland Pharma Limited (2) · HF Acquisition Co LLC, DBA HealthFirst (2) · Sagent Pharmaceuticals (2) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🧾 Billing Codes (HCPCS)

Medical billing codes (HCPCS "J-codes") that connect to this concept's packages — used mostly when a clinic or hospital bills for a drug it administers. Each code links to its full billing page.

Code	Descriptor	Mapped packages	Sources
J0153	Adenosine inj 1mg	6	CMS

⚠ A crosswalk is not coverage: an NDC↔HCPCS mapping does not guarantee any payer covers or pays the code. Always verify the current payer policy before billing.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7

openFDA export observedJul 14, 2026

RxNorm release07/06/2026

Methodology2026-07-full-catalog-v1

A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.

This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.